PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

9 Dec 2020 07:00

RNS Number : 9884H
Cenkos Securities PLC
09 December 2020
 

 

Cenkos Securities plc

9 December 2020

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

Board changes

 

Jim Durkin has informed the Board that he intends to retire as Chief Executive. Jim returned to lead the business in 2019, at a very difficult time for UK stockbrokers and successfully kept the Company profitable, led the restructuring of the Board and further strengthened governance.

 

The Board is pleased to announce that subject to FCA approval, Julian Morse, currently Executive Director and Head of the Growth Companies Team will be appointed Chief Executive. Julian joined Cenkos in its first year of operations and was a founding member of the Growth Companies Team, which he has led since 2016 and which has grown and performed strongly since.

 

Jim will continue in his role as Chief Executive and as a Director of the Company until Julian's appointment has been approved by the FCA and will then remain with the Company for a short period in order to facilitate a smooth transition of leadership through to March 2021.

 

The Board is also pleased to announce that subject to FCA approval, Jeremy Osler, Co-Head of Corporate Finance & General Counsel, is being appointed an Executive Director on the Board, in addition to his current role. Jeremy qualified as a lawyer and practiced with Ashurst before joining J.P. Morgan Cazenove and latterly Hannam & Partners. He joined Cenkos in 2016.

 

The Board has endorsed a strategy and organisational structure, designed to deliver sustainable growth and build shareholder value over the next 3 years and beyond. This strategy focuses on the core strengths of Cenkos and utilising the breadth and depth of talent that exists throughout the Company to continue to deliver exceptional results for its clients.

 

Commenting on the Board changes, Jim Durkin said:

 

"I will be leaving the Company in very good shape and I have every confidence that Julian will leverage his 25+ years' experience in the City to successfully lead the Company with the expert help of Jeremy, Lisa and the rest of the Board and Executive Committee. Our offices in London and Edinburgh have led some of the most successful transactions during 2020 including the IPOs of FRP Advisory, Round Hill Music Royalty Fund, Calnex Solutions and HeiQ. Whilst I will be stepping down from the Board, I look forward to watching the Company progress and intend to remain a supportive shareholder."

 

Julian Morse said:

 

"I am very excited to be taking over as Chief Executive of Cenkos, at what is a pivotal time for stockbrokers in the UK. With our focus, in particular, on growth companies, and investment trusts, we are well positioned to take advantage of the positive macro trends towards equity markets. Cenkos has always been and will remain nimble and share the entrepreneurial instincts of many of our clients, which enables us to flourish in periods of change.

 

Our people are our key asset, and I would like to thank them for all their hard work so far this year. We are approaching the end of the year with real momentum and I look forward to us continuing to drive returns for all our stakeholders. "

 

Chairman, Lisa Gordon said: "This year has been intense, and the challenges of Covid-19 have been well documented. In our case, we have performed well in 2020 and it has reinforced the Board's belief that Cenkos is made up of outstanding people. The Board has a shared vision for the Company's culture and structure going forward, which will provide opportunities for personal and professional development throughout the firm and secure Cenkos' continued success."

 

--End--

For further information contact:

Cenkos Securities plcLisa Gordon - Chairman +44 20 7397 8900

Nominated AdviserSpark Advisory Partners Limited - Matt Davis +44 20 3368 3550

Public RelationsBuchanan Communications - David Rydell +44 07798 646021

 

Additional Information

 

In accordance with the AIM Rules, the following information required to be disclosed in relation to Jeremy Osler is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full Name and age:

Jeremy Joseph Scott Osler aged 49

 

Current Directorships/Partnerships:

None

 

Previous Directorships/Partnerships:

Hannam & Partners LLP - LLP member resigned 18 March 2016

 

Current interest in the Company's share capital:

26,151 Ordinary shares of 1 pence held in an ordinary managed account.

65,515 Ordinary shares of 1 pence held in accordance with the terms and conditions of Company's Deferred Bonus Scheme.

8,274 Ordinary shares of 1 pence held through the Company's Share Incentive Plan.

Options over 44,698 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 40.27pence. These options expire on 30 June 2024.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATPBPTMTIMBAM
Date   Source Headline
27th Aug 20218:57 amRNSForm 8.5 (EPT/NON-RI)
26th Aug 20218:58 amRNSForm 8.5 (EPT/NON-RI)
25th Aug 20218:25 amRNSForm 8.5 (EPT/NON-RI)
24th Aug 20218:01 amRNSForm 8.5 (EPT/NON-RI)
23rd Aug 20218:32 amRNSForm 8.5 (EPT/NON-RI)
20th Aug 20218:20 amRNSForm 8.5 (EPT/NON-RI)
19th Aug 20218:24 amRNSForm 8.5 (EPT/NON-RI)
18th Aug 202110:16 amRNSForm 8.5 (EPT/NON-RI)
17th Aug 20219:20 amRNSForm 8.5 (EPT/NON-RI)
16th Aug 20218:32 amRNSForm 8.5 (EPT/NON-RI)
13th Aug 20218:39 amRNSForm 8.5 (EPT/NON-RI)
12th Aug 20219:05 amRNSForm 8.5 (EPT/NON-RI)
11th Aug 202110:00 amRNSForm 8.5 (EPT/NON-RI)
10th Aug 20219:52 amRNSForm 8.5 (EPT/NON-RI)
10th Aug 20219:44 amRNSForm 8.5 (EPT/NON-RI)
6th Aug 20218:37 amRNSForm 8.5 (EPT/NON-RI)
6th Aug 20218:35 amRNSForm 8.5 (EPT/NON-RI)
5th Aug 20219:23 amRNSForm 8.5 (EPT/NON-RI)
5th Aug 20219:22 amRNSForm 8.5 (EPT/NON-RI)
4th Aug 20218:41 amRNSForm 8.5 (EPT/NON-RI)
2nd Aug 20218:41 amRNSForm 8.5 (EPT/NON-RI)
30th Jul 20218:35 amRNSForm 8.5 (EPT/NON-RI)
30th Jul 20218:32 amRNSForm 8.5 (EPT/NON-RI)
29th Jul 20218:37 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 20219:06 amRNSForm 8.5 (EPT/NON-RI)
27th Jul 20218:20 amRNSForm 8.5 (EPT/NON-RI)
26th Jul 20219:29 amRNSForm 8.5 (EPT/NON-RI)
23rd Jul 20212:38 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
23rd Jul 202110:26 amRNSForm 8.5 (EPT/NON-RI)
23rd Jul 202110:23 amRNSForm 8.5 (EPT/NON-RI)
18th May 20213:58 pmRNSPDMR Dealings
12th May 20211:29 pmRNSResult of AGM
12th May 20217:00 amRNSAGM Statement
6th May 20213:06 pmRNSBoard Changes
21st Apr 20213:41 pmRNSDirectors Dealing
21st Apr 20217:00 amRNSEBT Share Purchase Plan
20th Apr 20214:34 pmRNSPDMR Dealings
16th Apr 20215:54 pmRNSBlock Admission Interim Review
9th Apr 20213:02 pmRNSDirector and PDMR Shareholdings - Grant of Awards
8th Apr 20215:41 pmRNSPosting of Annual Report and Notice of AGM
7th Apr 20216:16 pmRNSDirector and PDMR Shareholdings - LTIP Awards
29th Mar 20214:47 pmRNSDirector/PDMR Shareholding
23rd Mar 20214:06 pmRNSDirector/PDMR Shareholding
22nd Mar 20211:56 pmRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amRNSAnnual Results for the year ended 31 December 2020
19th Mar 20218:29 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 20219:04 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 20218:22 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 20219:27 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 20218:36 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.